跳至主要内容
临床试验/CTRI/2025/09/095374
CTRI/2025/09/095374尚未招募3 期

Prospective Single Arm Interventional Study To Assess Effectiveness Of Individualised Homoeopathic Treatment In Managing Hypersensitivity In Cases Of Urticaria.

Dr Dhruvi Shah1 个研究点 分布在 1 个国家目标入组 49 人开始时间: 2025年10月5日最近更新:

试验速览

阶段
3 期
状态
尚未招募
发起方
入组人数
49
试验地点
1
主要终点
Improved patient reported quality of life

研究概览

简要总结

Urticaria is a common dermatological disorder with considerable global and national health impact, often associated with angioedema and recurrent episodes affecting quality of life. Despite the availability of conventional therapies, management remains suboptimal, especially in regions like India, due to limited diagnostic facilities, high costs, and inadequate control of relapses. Homeopathy approaches the condition from a holistic perspective, emphasizing the disturbance of vital force, susceptibility, and idiosyncrasy, which influence an individual’s reaction to external and internal stimuli. Environmental stressors, psychosomatic factors, and lifestyle habits further contribute to hypersensitivity responses leading to urticaria. In clinical evaluation, the CU-Q2OL scoring system provides a structured means to assess symptom intensity and quality of life before and after treatment, ensuring objective monitoring. By integrating clinical scoring with individualized homeopathic intervention, a more comprehensive and sustainable therapeutic outcome can be achieved, addressing both the physical manifestations and underlying psychosomatic dimensions.

研究设计

研究类型
Interventional
分配方式
Na
盲法
None

入排标准

年龄范围
5.00 Year(s) 至 80.00 Year(s)(—)
性别
All

入选标准

  • Cases of Urticaria irrespective of gender and 5-80 years of age.
  • Pre diagnosed cases already on allopathic treatment, but now switched to Homeopathic treatment.
  • Patients willing to give consent for the study.
  • Children from age 5 to 18 years willing to give assent and their parent’s will for consent.

排除标准

  • Cases with severe systemic disease and cannot be managed at opd level.
  • Pregnant females.

结局指标

主要结局

Improved patient reported quality of life

时间窗: Every follow up | And at the baseline

Changes in quality of life score [CU-Q2oL Score]

时间窗: Every follow up | And at the baseline

次要结局

  • Reduction in itching,burning and wheals.(Decreased redness and discomfort.)

研究者

发起方
Dr Dhruvi Shah
申办方类型
Other [self]
责任方
Principal Investigator
主要研究者

Dr Chirag Tamboli

Dr V. H. Dave Homoeopathic Medical College

研究点 (1)

Loading locations...

相似试验